Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Inhaled Iloprost in Pulmonary Hypertension Secondary to Pulmonary Fibrosis
NCT00439543Phase 3Unknown
- Start
- Mar 2007
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 3, open-label, single-arm trial of iloprost in pulmonary hypertension (PH). Primary endpoints: Safety, Pulmonary Arterial Pressure and 1 more. Status: unknown.
02
Drugs
iloprost
03
Conditions
pulmonary hypertension (PH)
Beyond the preview
Go deeper on NCT00439543.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00439543.